The platform will undergo maintenance on Sep 14 at about 7:45 AM EST and will be unavailable for approximately 2 hours.
2011
DOI: 10.1038/nrd3368
|View full text |Cite
|
Sign up to set email alerts
|

Impact of high-throughput screening in biomedical research

Abstract: High-throughput screening (HTS) has been postulated in several quarters to be a contributory factor to the decline in productivity in the pharmaceutical industry. Moreover, it has been blamed for stifling the creativity that drug discovery demands. In this article, we aim to dispel these myths and present the case for the use of HTS as part of a proven scientific tool kit, the wider use of which is essential for the discovery of new chemotypes.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

3
870
0
13

Year Published

2012
2012
2021
2021

Publication Types

Select...
5
5

Relationship

0
10

Authors

Journals

citations
Cited by 1,092 publications
(915 citation statements)
references
References 56 publications
3
870
0
13
Order By: Relevance
“…With developments in modern science and technology, isolation of bioactive components from natural sources and identification of their molecular mechanism of action in the living system became an important pharmacological research [8][9][10]. Several promising natural products and natural product-inspired compounds are currently in clinical and pre-clinical developmental stages for cancer treatment [7,[11][12][13]. Limited supply of active compounds from natural sources, difficulties in complete profiling of their cellular targets and characterization of their molecular mechanisms of Phytochemicals and their synthetic derivatives are making a significant contribution in modern drug discovery programs by targeting several human diseases, including cancer.…”
Section: Introductionmentioning
confidence: 99%
“…With developments in modern science and technology, isolation of bioactive components from natural sources and identification of their molecular mechanism of action in the living system became an important pharmacological research [8][9][10]. Several promising natural products and natural product-inspired compounds are currently in clinical and pre-clinical developmental stages for cancer treatment [7,[11][12][13]. Limited supply of active compounds from natural sources, difficulties in complete profiling of their cellular targets and characterization of their molecular mechanisms of Phytochemicals and their synthetic derivatives are making a significant contribution in modern drug discovery programs by targeting several human diseases, including cancer.…”
Section: Introductionmentioning
confidence: 99%
“…Although high-throughput screening using libraries of compounds is a proven way to identify novel entities [64], these highly artificial and non-physiological assay systems have low success rates. Moreover, this process is time-consuming and sample-intensive.…”
Section: Discussionmentioning
confidence: 99%
“…Les « big pharma » ont souvent eu recours aux deux stratégies. Le criblage de chimiothèques est largement utilisé dans l'industrie pharmaceutique dans le but d'accélérer la découverte de drogues [2,9] (➜) Dans le monde académique, le criblage n'a pas la même vocation.…”
Section: Naissance Des Chimiothèques Académiques Françaisesunclassified